Terug
Dr. S. Mook
Radiotherapeut-oncoloogAandachtsgebieden
- Gastro-intestinale tumoren
- Mammacarcinoom
Wetenschappelijk onderzoek
- Slokdarmkanker
- MRI-gestuurde radiotherapie
Lidmaatschap beroepsorganisaties
Subsidies, Grants, Awards
2006-2007
- TRANSBIG traineeship
2011
- Antoni van Leeuwenhoek prijs
- AMC Graduate School Excellent Thesis price
- NVMO Oncologieproefschrift van het jaar
Publicaties
Key publications
- Mook S, Van 't Veer LJ, Rutgers EJ, Ravdin PM, van de Velde AO, van Leeuwen FE, Visser O, Schmidt MK. Independent prognostic value of screen detection in invasive breast cancer. J Natl Cancer Inst. 2011 Apr 6;103(7):585-97.
- Mook S, Schmidt MK, Rutgers EJ, van de Velde AO, Visser O, Rutgers SM, Armstrong N, van ’t Veer LJ, Ravdin PM. Calibration and discriminatory accuracy of the web-based tool Adjuvant! in a cohort of 5380 Dutch breast cancer patients. Lancet Oncol. 2009 Nov;10(11):1070-6.
- Mook S, Schmidt MK, Viale G, Pruneri G, Eekhout I, Floore A, Glas AM, Bogaerts J, Cardoso F, Piccart-Gebhart MJ, Rutgers ET, Van't Veer LJ; On behalf of the TRANSBIG consortium. The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1-3 positive lymph nodes in an independent validation study. Breast Cancer Res Treat. 2009 Jul;116(2):295-302.
- Mook S, Bonnefoi H, Pruneri G, Larsimont D, Jaskiewicz J, Sabadell MD, Macgrogan G, Van't Veer LJ, Cardoso F, Rutgers EJ. Daily clinical practice of fresh tumour tissue freezing and gene expression profiling; logistics pilot study preceding the MINDACT trial. Eur J Cancer. 2009 May;45(7):1201-8.
PubMed
Korte biografie
1996 - 2003 | Studie Geneeskunde, Universiteit Utrecht |
2005 - 2009 | Promotie onderzoek Antoni van Leeuwenhoek ziekenhuis |
2011 | Promotie “Prognostic factors in breast cancer; one fits all?” (cum laude), Universiteit van Amsterdam |
2009 - 2015 | Opleiding tot radiotherapeut-oncoloog, Antoni van Leeuwenhoek ziekenhuis |
Aug. 2015 | Staflid afdeling Radiotherapie UMC Utrecht |